From GlobeNewswire: 2025-04-14 19:00:00

MediciNova, Inc. CEO and CBO will be at the DBC Conference on May 14, 2025, in NYC, discussing leading programs in neurologic and metabologic disorders. The company focuses on developing therapeutics for ALS, MS, neuropathy, addiction, ARDS, Long COVID, fibrosis, NAFLD, and more. MediciNova plans to advance their pipeline through clinical trials, government grants, or strategic alliances. Forward-looking statements in the press release highlight the risks involved in the development and efficacy of their lead programs. For more information about participation in the DBC Conference, visit https://dboralcapital.com/conference.



Read more at GlobeNewswire: MediciNova To Participate in D. Boral’s Capital Global